Esther Rajavelu
Stock Analyst at UBS
(0.51)
# 2,965
Out of 4,479 analysts
18
Total ratings
46.15%
Success rate
-17.25%
Average return
Main Sectors:
Top Industries:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $21.74 | +47.19% | 2 | Apr 9, 2024 | |
| APLT Applied Therapeutics | Maintains: Buy | $12 → $13 | $4.35 | +198.85% | 2 | Mar 15, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | n/a | $247.61 | - | 1 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | n/a | $40.96 | - | 1 | Aug 19, 2021 | |
| BHVN Biohaven Pharmaceutical Holding Company | Downgrades: Neutral | n/a | $34.17 | - | 4 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | n/a | $12.83 | - | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | n/a | $45.14 | - | 2 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | n/a | $105.09 | - | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $0.74 | - | 1 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $25.22 | - | 1 | Dec 13, 2019 | |
| INVA Innoviva | Initiates: Hold | n/a | $16.50 | - | 1 | Nov 20, 2017 | |
| TXMD TherapeuticsMD | Initiates: Buy | n/a | $1.66 | - | 1 | Jul 21, 2017 |
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $21.74
Upside: +47.19%
Applied Therapeutics
Mar 15, 2024
Maintains: Buy
Price Target: $12 → $13
Current: $4.35
Upside: +198.85%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: n/a
Current: $247.61
Upside: -
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: n/a
Current: $40.96
Upside: -
Biohaven Pharmaceutical Holding Company
Aug 10, 2021
Downgrades: Neutral
Price Target: n/a
Current: $34.17
Upside: -
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: n/a
Current: $12.83
Upside: -
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: n/a
Current: $45.14
Upside: -
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: n/a
Current: $105.09
Upside: -
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $0.74
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $25.22
Upside: -
Innoviva
Nov 20, 2017
Initiates: Hold
Price Target: n/a
Current: $16.50
Upside: -
TherapeuticsMD
Jul 21, 2017
Initiates: Buy
Price Target: n/a
Current: $1.66
Upside: -